findmyKOL
Clinical trialNCT01265498CompletedPhase 2Interventional

The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)

SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrollment283Nonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis (NASH)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Edward Doo, MD

    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California, San Diego

    San Diego, California, United States

  • University of California, San Francisco

    San Francisco, California, United States

  • Indiana University

    Indianapolis, Indiana, United States

  • St. Louis University

    St Louis, Missouri, United States

  • Duke University Medical Center

    Durham, North Carolina, United States

  • Case Western Reserve University

    Cleveland, Ohio, United States

  • Cleveland Clinic Foundation

    Cleveland, Ohio, United States

  • Virginia Commonwealth University

    Richmond, Virginia, United States

  • Virginia Mason Medical Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2011
Primary completion
31 Jan 2014
Completion
30 Sept 2014
Last update posted
6 Apr 2018
Registered enrollment
283
Registry id
NCT01265498

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.